Apeiron Investment Group Ltd. 13D and 13G filings for Atai Life Sciences N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:29 pm Purchase | 2023-12-31 | 13G | Atai Life Sciences N.V. ATAI | Apeiron Investment Group Ltd. | 33,885,999 20.100% | 1,214,297 (+3.72%) | Filing |
| 2023-02-10 08:39 am Purchase | 2022-12-31 | 13G | Atai Life Sciences N.V. ATAI | Apeiron Investment Group Ltd. | 32,671,702 19.400% | 612,198 (+1.91%) | Filing |
| 2022-02-10 5:01 pm Purchase | 2021-12-31 | 13G | Atai Life Sciences N.V. ATAI | Apeiron Investment Group Ltd. | 32,059,504 19.700% | 32,059,504 (New Position) | Filing |